New Technique May Lead to Safer Stem Cell Transplants For hard-to-treat leukemias, lymphomas and other blood cancers, stem cell transplantation is the gold standard of care. The procedure involves replacing a patient’s own blood-forming stem cells with a donor’s stem cells and, in the process, eradicating cancer cells in the
Steroid-Sparing Regimens Lower Risk of Diabetes Mellitus After Transplant in Some Adults Steroid avoidance can lower the risk of diabetes mellitus after transplant in older patients or those who have higher BMIs when paired with appropriate induction regimens, according to data published in Kidney Medicine. Read more...
Antidepressant May Prevent Severe COVID-19, Follow-up Study Indicates In the largest study yet to evaluate a common, low-cost antidepressant as a treatment for COVID-19, researchers from Washington University School of Medicine in St. Louis and from Canada and Brazil have found that the drug fluvoxamine prevents some of the most
Graduate School of the Stowers Institute Receives Accreditation The Graduate School of the Stowers Institute for Medical Research announced today that it has received institutional accreditation from the Higher Learning Commission, an accrediting agency recognized by the U.S. Department of Education and the Council for Higher Education Accreditation. Read more...
Dr. Joyce Balls-Berry Dr. Joyce Balls-Berry is an Associate Professor of Neurology at Washington University School of Medicine and Core Leader for the newly established Health Disparities and Equity Core in the Knight ADRC (Center Director John Morris, MD). Her primary research focuses on applying community and
Kelly Fischer, Chief People Officer at Benson Hill This month’s WISER Woman is Kelly Fischer. Kelly is the Chief People Officer at Benson Hill. She is a seasoned human resources professional with a breadth of experience in talent strategy, project leadership, change management, and communications. Not only
International Alzheimer’s Clinical Trial to Test Two Drugs in Combination Researchers leading a worldwide clinical trial aimed at finding treatments for Alzheimer’s disease are modifying an arm of the trial to evaluate a combination of drugs targeting two brain proteins: amyloid and tau. The trial – known as the Tau
In an Astonishing Feat, a New Drug Reversed Paralysis in Mice With Spinal Cord Injury US scientists have developed a new form of drug that promotes the regeneration of cells and reversed paralysis in mice with spinal injuries, allowing them to walk again within four weeks of treatment. Read more...
Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s
Turning CAR-T Tech Against Solid Tumors by Targeting Protein Fragments in Cancer Cells CAR-T therapies, which arm a patient’s own immune cells with cancer-fighting proteins, are currently used to treat some patients with blood cancers. But the technology has been hard to apply to other cancers, partly because of a